Key result
Digoxin treatment for 8 weeks improved right ventricular ejection fraction in patients with pulmonary heart disease only when the left ventricular ejection fraction was also initially abnormal.
Why the study?
Does digoxin improve right and left ventricular ejection fractions in patients with pulmonary heart disease caused by severe chronic airflow obstruction?
RCT (n=15)
Double-blind
randomized
Does digoxin improve right and left ventricular ejection fractions in patients with pulmonary heart disease caused by severe chronic airflow obstruction?
Digoxin improves right ventricular ejection fraction in patients with pulmonary heart disease only if they have concurrent left ventricular dysfunction.
Reserve digoxin for pulmonary heart disease with reduced LVEF; challenges routine use and extends subgroup-specific RCT evidence.
The effect of digoxin on the right and left ventricular ejection fractions in 15 patients with pulmonary heart disease caused by severe chronic airflow obstruction was studied in a double-blind, randomized, placebo-controlled trial. All patients were ambulatory and had clinical features of right but not left ventricular dysfunction. Equilibrium radionuclide angiography showed reduced right ventricular ejection fraction in all patients and reduced left ventricular ejection fraction in four. After 8 weeks of digoxin treatment, the abnormal left ventricular ejection fractions were normal; right ventricular ejection fractions increased only in those patients who had had abnormal left ventricular ejection fractions. We conclude that in patients with pulmonary heart disease, the right ventricular ejection fraction is abnormal and improves with digoxin treatment only when the left ventricular ejection fraction also is initially abnormal.
No takes yet. Share an insight, caveat, or question.
Praveen N. Mathur (1981) conducted an RCT in Pulmonary heart disease caused by severe chronic airflow obstruction (n=15). Digoxin vs. Placebo was evaluated on Right and left ventricular ejection fractions. Digoxin treatment for 8 weeks improved right ventricular ejection fraction in patients with pulmonary heart disease only when the left ventricular ejection fraction was also initially abnormal.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: